Social media is packed with misinformation about taking weight-loss medications, including that your food choices dont matter because youll lose weight no matter what
Scientific Research Review SURPASS Clinical Trial Program (Type 2 Diabetes) The SURPASS program comprised phase III trials evaluating tirzepatide 5, 10, and 15 mg once weekly in patients with type 2 diabetes: SURPASS-1 (monotherapy, n=478): Tirzepatide reduced HbA1c by 1.87% (5 mg), 1.89% (10 mg), and 2.07% (15 mg) vs
Accidental overdoses of semaglutide have surged in recent years as more injected drugs containing this ingredient have come on the market to treat diabetes and aid weight loss
This used a more concentrated extract, but the effect was modest
According to a 2023 study referenced in sources below (3), the prevalence of diabetes in the US increases with age, peaking around the 60s among males